Management of hypertension in the setting of autonomic failure: A pathophysiological approach

Hypertension

Volumn 45, Issue 4, 2005, Pages 469-476

  Shibao, Cyndya ^b   Gamboa, Alfredo ^b   Diedrich, André ^b   Biaggioni, Italo ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b NONE

Author keywords

Atrophy; Autonomic nervous system; Hypertension; Hypotension

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; LEVODOPA; VERAPAMIL;

AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CLINICAL FEATURE; CONFUSION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DIZZINESS; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; HYPERTENSION; MALE; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SUPRAVENTRICULAR PREMATURE BEAT; TREATMENT OUTCOME; VISUAL HALLUCINATION;

AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSION; HYPOTENSION, ORTHOSTATIC; MALE; SUPINE POSITION;

EID: 15744369476     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000158835.94916.0c     Document Type: Article

References (58)

1. Luukinen H, Koski K, Laippala P, Kivela SL. Prognosis of diastolic and systolic orthostatic hypotension in older persons. Arch Intern Med. 1999; 159:273-280.
2. Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension. 1992;19:508-519.
3. Klein CM, Vernino S, Lennon VA, Sandroni P, Fealey RD, Benrud-Larson L, Sletten D, Low PA. The spectrum of autoimmune autonomic neuropathies. Ann Neurol. 2003;53:752-758.
4. Vernino S, Adamski J, Kryzer TJ, Fealey RD, Lennon VA. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurol. 1998;50:1806-1813.
5. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847-855.
6. Sandroni P, Vernino S, Klein CM, Lennon VA, Benrud-Larson L, Sletten D, Low PA. Idiopathic autonomic neuropathy: comparison of cases sero-positive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol. 2004;61:44-48.
7. Parikh SM, Diedrich A, Biaggioni I, Robertson D. The nature of the autonomic dysfunction in multiple system atrophy. J Neurol Sci. 2002; 200:1-10.
8. Hague K, Lento P, Morgello S, Caro S, Kaufmann H. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol. 1997;94:192-196.
9. Kaufmann H, Hague K, Perl D. Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure. Neurol. 2001;56:980-981.
10. Kaufmann H, Nahm K, Purohit D, Wolfe D. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurol. 2004;63:1093-1095.
11. Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, Aiba I, Abe Y, Tamakoshi A, Doyu M, Hirayama M, Sobue G. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain. 2002;125:1070-1083.
12. Appenzeller O, Kornfeld M. Acute pandysautonomia. Clinical and morphologic study. Arch Neurol. 1973;29:334-339.
13. Young RR, Asbury AK, Corbett JL, Adams RD. Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria. Brain. 1975;98:613-636.
14. Schroeder C, Birkenfeld A, Heusser K, Kettritz R, Luft FC, Vernino S, Jordan J. Removal of antagonistic antibodies against ganglionic nicotinic receptors by plasma exchange in a case of severe autonomic failure: a cure for "the hexamethonium man"? Clin Autonom Res. 2004;14:317.
15. Goldstein DS, Holmes C, Sharabi Y, Brentzel S, Eisenhofer G. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurol. 2003;60:1327-1332.
16. Diedrich A, Jordan J, Tank J, Shannon JR, Robertson R, Luft FC, Robertson D, Biaggioni I. The sympathetic nervous system in hypertension: assessment by blood pressure variability and ganglionic blockade. J Hypertens. 2003;21:1677-1686.
17. Golstein DS, Holmes C, Cannon RO, Eisenhofer G, Kopin JJ. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med. 1997;336(10): 696-702.
18. Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I] MIBG separates Parkinson's disease from multiple systematrophy. Neurol. 1999;53:1020-1025.
19. Kaufmann H, Oribe E, Miller M, Knott P, Wiltshire-Clement M, Yahr MD. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurol. 1992;42:590-593.
20. Kimber JR, Watson L, Mathias CJ. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. Lancet. 1997;349:1877-1881.
21. Niimi Y, Ieda T, Hirayama M, Koike Y, Sobue G, Hasegawa Y, Takahashi A. Clinical and physiological characteristics of autonomic failure with Parkinson's disease. Clin Auton Res. 1999;9:139-144.
22. Bhattacharya K, Saadia D, Eisenkraft B, Yahr M, Olanow W, Drayer B, Kaufmann H. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol. 2002;59:835-842.
23. Shannon JR, Diedrich A, Biaggioni I, Tank J, Robertson RM, Robertson D, Jordan J. Water drinking as a treatment for orthostatic syndromes. Am J Med. 2002;112:355-360.
24. Hickler RB, Thompson GR, Fox LM, Hamlin JT, III. Successful treatment of orthostatic hypotension with 9-alpha-fluorohydrocortisone. N Engl J Med. 1959;261:788-791.
25. van Lieshout JJ, Ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res. 2000;10:35-42.
26. Biaggioni I, Robertson D, Krantz S, Jones M, Haile V. The anemia of autonomic failure: Evidence for sympathetic modulation of erythropoiesis in humans and reversal with recombinant erythropoietin. Ann Int Med. 1994;121:181-186.
27. Hoeldtke RD, Streeten DHP. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med. 1993;329:611-615.
28. Perera R, Isola L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res. 1995;5:211-213.
29. Ando Y, Asahara K, Obayashi K, Suhr O, Yonemitsu M, Yamashita T, Tashima K, Uchino M, Ando M. Autonomic dysfunction and anemia in neurologic disorders. J Auton Nerv Syst. 1996;61:145-148.
30. Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care. 2001;24:495-499.
31. Jordan J, Shannon JR, Biaggioni I, Norman R, Black BK, Robertson D. Contrasting actions of pressor agents in severe autonomic failure. Am J Med. 1998;105:116-124.
32. Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74:1294-1298.
33. Biaggioni I, Zygmunt D, Haile V, Robertson D. Pressor effect of inhaled ergotamine in orthostatic hypotension. Am J Cardiol. 1990;65:89-92.
34. Dewey RB, Jr., Rao SD, Holmburg SL, Victor RG. Ergotamine/caffeine treatment of orthostatic hypotension in parkinsonism with autonomic failure. Eur J Neurol. 1998;5:593-599.
35. Victor RG, Talman WT. Comparative effects of clonidine and dihydro-ergotamine on venomotor tone and orthostatic tolerance in patients with severe hypoadrenergic orthostatic hypotension. Am J Med. 2002;112: 361-368.
36. Bobik A, Jennings G, Skews H, Esler M, McLean A. Low oral bioavailability of dihydroergotamine and first-pass extraction in patients with orthostatic hypotension. Clin Pharmacol Ther. 1981;30:673-679.
37. Olver IN, Jennings GL, Bobik A, Esler M. Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension. BMJ. 1980;281:275-276.
38. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR. Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metabol. 1998;83:339-343.
39. Diedrich A, Biaggioni I. Segmental orthostatic fluid shifts. Clin Auton Res. 2004;14:146-147.
40. Shannon JR, Jordan J, Diedrich A, Pohar B, Black BK, Robertson D, Biaggioni I. Sympathetically mediated hypertension in autonomic failure. Circulation. 2000;101:2710-2715.
41. Jordan J, Shannon JR, Pohar B, Paranjape SY, Robertson D, Robertson RM, Biaggioni I. Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Amer Soc Nephrol. 1999;10:35-42.
42. Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension. 1997;30: 1062-1067.
43. Mathias CJ, daCosta DF, McIntosh CM, Fosbraey P, Bannister R, Wood SM, Bloom SR, Christensen NJ. Differential blood pressure and hormonal effects after glucose and xylose ingestion in chronic autonomic failure. Clin Sci. 1989;77:85-92.
44. Robertson D, Wade D, Robertson RM. Postprandial alterations in cardiovascular hemodynamics in autonomic dysfunctional states. Am J Cardiol. 1981;48:1048-1052.
45. Lipsitz LA, Pluchino FC, Wei JY, Minaker KL, Rowe JW. Cardiovascular and norepinephrine responses after meal consumption in elderly (older than 75 years) persons with postprandial hypotension and syncope. Am J Cardiol. 1986;58:810-815.
46. Lipsitz LA, Nyquist RP, Wei JY, Rowe JW. Postprandial reduction in blood pressure in the elderly. N Engl J Med. 1983;309:81-83.
47. Polinsky RJ, Kopin IJ, Ebert MH, Weise V. The adrenal medullary response to hypoglycemia in patients with orthostatic hypotension. J Endocrinol Metabol. 1980;51:1401-1406.
48. Brown RT, Polinsky RJ, Lee GK, Deeter JA. Insulin-induced hypotension and neurogenic orthostatic hypotension. Neurol. 1986;36:1402-1406.
49. Mathias CJ, daCosta DF, Fosbraey P, Christensen NJ, Bannister R. Hypotensive and sedative effects of insulin in autonomic failure. BMJ. 1987;295:161-163.
50. Brown RT, Polinsky RJ, Baucom CE. Euglycemic insulin-induced hypotension in autonomic failure. Clin Neuropharmacol. 1989;12:227-231.
51. Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens. 2001;14:304S-309S.
52. Biaggioni I. Postural hypotension. In: Lebovitz HE, ed. Therapy of Diabetes Mellitus and Related Disorders. Alexandria, Va: American Diabetes Association, Inc; 1991.
53. Jacob G, Costa F, Biaggioni I. Spectrum of autonomic cardiovascular neuropathy in diabetes. Diabetes Care. 2003;26:2174-2180.
54. Biaggioni I, Onrot J, Stewart CK, Robertson D. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment. JAMA. 1987;258:236-239.
55. Kerman WN, Viscoli CM, Brass LM, Broderick JP, Brott T, Feldmann E, Morgenstern LB, Wilterdink JL, Horwitz RI. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343:1826-1832.
56. Jordan J, Shannon JR, Black BK, Ali Y, Farley M, Costa F, Diedrich A, Robertson RM, Biaggioni I, Robertson D. The pressor response to water drinking in humans: a sympathetic reflex? Circulation. 2000;101: 504-509.
57. Diedrich A, Jordan J, Shannon JR, Robertson D, Biaggioni I. Modulation of QT interval during autonomic nervous system blockade in humans. Circulation. 2002;106:2238-2243.
58. Murakami T, Shoji M, Imai Y, Inoue H, Kawarabayashi T, Matsubara E, Harigaya Y, Sasaki A, Takahashi R, Abe K. Pael-R is accumulated in Lewy bodies of Parkinson's disease. Ann Neurol. 2004;55:439-442.